ABVC Biopharma Inc
NASDAQ:ABVC
ABVC Biopharma Inc
NASDAQ:ABVC
Price:
1.08 USD
-6.09%
Market Closed
Updated:
May 5, 2024
ABVC Biopharma Inc
Cash from Investing Activities
|
ABVC Biopharma Inc
Cash from Investing Activities Peer Comparison
Comparables:
AMGN
ALNY
KRTX
MRNA
SRPT
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ABVC Biopharma Inc
NASDAQ:ABVC
|
Cash from Investing Activities
-$360.2k
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Investing Activities
-$26.2B
|
CAGR 3-Years
-69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
Cash from Investing Activities
-$336.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
|
Karuna Therapeutics Inc
NASDAQ:KRTX
|
Cash from Investing Activities
-$160.3m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-99%
|
CAGR 10-Years
N/A
|
|
|
Moderna Inc
NASDAQ:MRNA
|
Cash from Investing Activities
$4.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sarepta Therapeutics Inc
NASDAQ:SRPT
|
Cash from Investing Activities
$40.5m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ABVC Biopharma Inc's Cash from Investing Activities?
Cash from Investing Activities
-360.2k
USD
-360.2k
USD
Based on the financial report for Dec 31, 2023, ABVC Biopharma Inc's Cash from Investing Activities amounts to -360.2k USD.
What is ABVC Biopharma Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-18%
-18%
Over the last year, the Cash from Investing Activities growth was 79%. The average annual Cash from Investing Activities growth rates for ABVC Biopharma Inc have been -16% over the past three years , -18% over the past five years .
You don't have any saved screeners yet
